Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis
Clinical trial NCT05407246 · COMPLETED
Trial details
- NCT number
- NCT05407246
- Sponsor
- Tianjin Hemay Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-05
- Primary completion
- 2023-08-18
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.